Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T08391 | Target Info | |||
Target Name | Janus kinase 2 (JAK-2) | ||||
Synonyms | Tyrosine-protein kinase JAK2 | ||||
Target Type | Successful Target | ||||
Gene Name | JAK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Protein Name | Growth factor receptor-bound protein 2 (GRB2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SH2/SH3 adapter GRB2; Protein Ash; Growth factor receptor-bound protein 2; ASH; Adapter protein GRB2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Cytokine receptors | [+] 2 Cytokine receptors | + | |||
Interacting Target Name | Erythropoietin Receptor (EPOR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Full-length form; EPO-R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [3] | |||
2 | Reconstituted Complex | [4] | |||
Interacting Target Name | Growth hormone receptor (GHR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Somatotropin receptor; Serum bindingprotein; Growth hormone receptor; GH receptor | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Co-fractionation | [6] | |||
Ester hydrolases | [+] 2 Ester hydrolases | + | |||
Interacting Target Name | Protein-tyrosine phosphatase SHP-2 (PTPN11) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 11; SH-PTP3; SH-PTP2; SHPTP2; SHP-2; SHP2; PTP-2C; PTP2C; PTP-1D; Protein-tyrosine phosphatase SHP2; Protein-tyrosine phosphatase 2C; Protein-tyrosine phosphatase 1D | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Biochemical Activity | [8] | |||
3 | Biochemical Activity | [9] | |||
Interacting Target Name | Protein-tyrosine phosphatase 1B (PTP1B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 1; PTP-1B | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Biochemical Activity | [11] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Biochemical Activity | [13] | |||
3 | Protein-peptide | [14] | |||
One-carbon transferases | [+] 1 One-carbon transferases | + | |||
Interacting Target Name | Protein arginine methyltransferase 5 (PRMT5) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SKB1Hs; SKB1 homolog; SKB1; Shk1 kinase-binding protein 1 homolog; Protein arginine N-methyltransferase 5; JBP1; Jak-binding protein 1; IBP72; HRMT1L5; Histone-arginine N-methyltransferase PRMT5; 72 kDa ICln-binding protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Biochemical Activity | [15] | |||
3 | Yeast two hybrid | [16] | |||
Transcription regulators | [+] 4 Transcription regulators | + | |||
Interacting Target Name | Signal transducer and activator of transcription 3 (STAT3) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor STAT3; Stat3; Signal transducer and activator of transcription 3; APRF; Acute-phase response factor | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Affinity Capture-Western | [18] | |||
3 | Biochemical Activity | [13] | |||
4 | Biochemical Activity | [19] | |||
Interacting Protein Name | Signal transducer and activator of transcription 5A (STA5A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MGF; STAT5 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [20] | |||
2 | Reconstituted Complex | [21] | |||
3 | Yeast two hybrid | [21] | |||
Interacting Target Name | Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor ISGF-3 components p91/p84; STAT-1; Signal transducers and activators of transcription factor; Signal transducer and activator of transcription 1-alpha/beta; P91 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Co-localization | [23] | |||
Interacting Protein Name | Signal transducer and activator of transcription 5B (STA5B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STAT5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [24] | |||
2 | Yeast two hybrid | [21] | |||
Other proteins | [+] 5 Other proteins | + | |||
Interacting Target Name | Suppressor of cytokine signaling 1 (SOCS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TIP-3; TIP3; Tec-interacting protein 3; STAT-induced STAT inhibitor 1; STAT induced STAT inhibitor 1; SSI-1; SSI1; SOCS-1; JAK-binding protein; JAB | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Affinity Capture-Western | [26] | |||
3 | Affinity Capture-Western | [27] | |||
4 | Affinity Capture-Western | [28] | |||
5 | Affinity Capture-Western | [29] | |||
6 | Reconstituted Complex | [30] | |||
7 | Yeast two hybrid | [31] | |||
8 | Yeast two hybrid | [32] | |||
Interacting Target Name | Suppressor of cytokine signaling 3 (SOCS3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STAT-induced STAT inhibitor 3; STAT induced STAT inhibitor 3; SSI-3; SSI3; SOCS-3; Cytokine-inducible SH2 protein 3; CIS-3; CIS3 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [33] | |||
2 | Affinity Capture-Western | [34] | |||
3 | Affinity Capture-Western | [29] | |||
4 | Reconstituted Complex | [35] | |||
5 | Reconstituted Complex | [30] | |||
6 | Reconstituted Complex | [24] | |||
7 | Yeast two hybrid | [35] | |||
Interacting Protein Name | Proto-oncogene vav (VAV1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VAV | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Affinity Capture-Western | [37] | |||
3 | Biochemical Activity | [36] | |||
Interacting Target Name | Tumor necrosis factor receptor type I (TNF-R1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor necrosis factor-binding protein 1; Tumor necrosis factor receptor superfamily member 1A; Tumor necrosis factor receptor 1; TNF-RI; TNFR-I; TNFR1; TNFAR; TBPI; p60; p55; CD120a | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [38] | |||
2 | Reconstituted Complex | [38] | |||
Interacting Target Name | Insulin receptor substrate-1 (IRS1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRS-1; Insulin receptor substrate 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Biochemical Activity | [40] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells. J Exp Med. 1995 Dec 1;182(6):1801-6. | ||||
REF 2 | Involvement of Janus kinases in the insulin signaling pathway. Eur J Biochem. 1995 Dec 1;234(2):656-60. | ||||
REF 3 | The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell. 2001 Dec;8(6):1327-38. | ||||
REF 4 | JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993 Jul 30;74(2):227-36. | ||||
REF 5 | Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem. 1995 Jun 16;270(24):14776-85. | ||||
REF 6 | Multimeric growth hormone receptor complexes serve as signaling platforms. J Biol Chem. 2014 Jan 3;289(1):65-73. | ||||
REF 7 | SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates. Biochem Biophys Res Commun. 1996 Nov 1;228(1):122-7. | ||||
REF 8 | Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem. 1997 Jan 10;272(2):1032-7. | ||||
REF 9 | Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood. 1996 Jun 1;87(11):4495-501. | ||||
REF 10 | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem. 2001 Dec 21;276(51):47771-4. | ||||
REF 11 | Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol. 2005 Apr;34(2):339-51. | ||||
REF 12 | ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem. 1999 Jun 11;274(24):17209-18. | ||||
REF 13 | Blockade of glioma proliferation through allosteric inhibition of JAK2. Sci Signal. 2013 Jul 9;6(283):ra55. | ||||
REF 14 | A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74. | ||||
REF 15 | JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell. 2011 Feb 15;19(2):283-94. | ||||
REF 16 | The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem. 1999 Oct 29;274(44):31531-42. | ||||
REF 17 | Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem. 1997 Jul 11;272(28):17694-702. | ||||
REF 18 | EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol. 2004 Dec;287(6):G1227-37. | ||||
REF 19 | Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival. Br J Cancer. 2016 Jul 12;115(2):212-22. | ||||
REF 20 | Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 1994 Sep 15;13(18):4361-9. | ||||
REF 21 | An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Oncogene. 1997 Feb 20;14(7):751-61. | ||||
REF 22 | Stat1 mediates an auto-regulation of hsp90beta gene in heat shock response. Cell Signal. 2010 Aug;22(8):1206-13. | ||||
REF 23 | Jak/STAT signaling pathway regulates nox1 and nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):105-12. | ||||
REF 24 | Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses. Biochem J. 2014 Mar 1;458(2):395-405. | ||||
REF 25 | Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol. 2002 May;22(10):3316-26. | ||||
REF 26 | SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor. J Biol Chem. 2003 Dec 26;278(52):52021-31. | ||||
REF 27 | The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells. Oncogene. 2001 Feb 15;20(7):849-58. | ||||
REF 28 | JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1. J Biol Chem. 2009 May 15;284(20):13481-8. | ||||
REF 29 | Negative regulation of FAK signaling by SOCS proteins. EMBO J. 2003 Oct 1;22(19):5036-46. | ||||
REF 30 | Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun. 1997 Oct 20;239(2):439-46. | ||||
REF 31 | The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 1999 Mar 1;18(5):1309-20. | ||||
REF 32 | A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 1997 Jun 26;387(6636):921-4. | ||||
REF 33 | CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem. 2000 Sep 22;275(38):29338-47. | ||||
REF 34 | Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems. Endocrinology. 2005 Feb;146(2):579-88. | ||||
REF 35 | Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells. 1999 Jun;4(6):339-51. | ||||
REF 36 | Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J Biol Chem. 1997 May 30;272(22):14334-40. | ||||
REF 37 | Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J. 1995 Jan 16;14(2):257-65. | ||||
REF 38 | Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol. 1998 Mar 15;160(6):2742-50. | ||||
REF 39 | Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med. 2001 Jan 15;193(2):263-9. | ||||
REF 40 | Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology. 1998 Mar;139(3):884-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.